Unknown

Dataset Information

0

Molecular cause and functional impact of altered synaptic lipid signaling due to a prg-1 gene SNP.


ABSTRACT: Loss of plasticity-related gene 1 (PRG-1), which regulates synaptic phospholipid signaling, leads to hyperexcitability via increased glutamate release altering excitation/inhibition (E/I) balance in cortical networks. A recently reported SNP in prg-1 (R345T/mutPRG-1) affects ~5 million European and US citizens in a monoallelic variant. Our studies show that this mutation leads to a loss-of-PRG-1 function at the synapse due to its inability to control lysophosphatidic acid (LPA) levels via a cellular uptake mechanism which appears to depend on proper glycosylation altered by this SNP. PRG-1(+/-) mice, which are animal correlates of human PRG-1(+/mut) carriers, showed an altered cortical network function and stress-related behavioral changes indicating altered resilience against psychiatric disorders. These could be reversed by modulation of phospholipid signaling via pharmacological inhibition of the LPA-synthesizing molecule autotaxin. In line, EEG recordings in a human population-based cohort revealed an E/I balance shift in monoallelic mutPRG-1 carriers and an impaired sensory gating, which is regarded as an endophenotype of stress-related mental disorders. Intervention into bioactive lipid signaling is thus a promising strategy to interfere with glutamate-dependent symptoms in psychiatric diseases.

SUBMITTER: Vogt J 

PROVIDER: S-EPMC4718157 | biostudies-literature | 2016 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications


Loss of plasticity-related gene 1 (PRG-1), which regulates synaptic phospholipid signaling, leads to hyperexcitability via increased glutamate release altering excitation/inhibition (E/I) balance in cortical networks. A recently reported SNP in prg-1 (R345T/mutPRG-1) affects ~5 million European and US citizens in a monoallelic variant. Our studies show that this mutation leads to a loss-of-PRG-1 function at the synapse due to its inability to control lysophosphatidic acid (LPA) levels via a cell  ...[more]

Similar Datasets

| S-EPMC3716297 | biostudies-literature
2022-05-13 | GSE202800 | GEO
| S-EPMC6776116 | biostudies-literature
2023-11-14 | PXD017997 | Pride
2021-09-27 | MTBLS1531 | MetaboLights
| S-EPMC7931347 | biostudies-literature
| S-EPMC3234282 | biostudies-literature
| S-EPMC5065528 | biostudies-literature
| S-EPMC6230693 | biostudies-literature
| PRJNA837272 | ENA